Physician perceptions and beliefs of phase I trials in pediatric oncology | Zendy

Gilliam Margaux B. | Zendy; MadanSwain Avi | Zendy; Adams Julia M. | Zendy; Pressey Joseph G. | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

Physician perceptions and beliefs of phase I trials in pediatric oncology

Author(s) -

Gilliam Margaux B.,

MadanSwain Avi,

Adams Julia M.,

Pressey Joseph G.

Publication year - 2013

Publication title -

pediatric blood and cancer

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.116

H-Index - 105

eISSN - 1545-5017

pISSN - 1545-5009

DOI - 10.1002/pbc.24522

Subject(s) - medicine , pediatric oncology , referral , blood cancer , family medicine , clinical trial , perception , phase (matter) , oncology , cancer , chemistry , organic chemistry , neuroscience , biology

The identification and referral of candidate patients for phase I trials relies heavily on pediatric oncologists who must balance their own perceptions of phase I trials with the desires of the patient and his/her family. A survey was sent to 419 physicians practicing pediatric oncology at 30 different institutions. Results indicated significant differences between physicians who practiced at institutions that participated in phase I consortia versus those who did not. The findings of the survey may be used to enhance the design and execution of phase I trials and to educate oncologists about the goals of phase I trials. Pediatr Blood Cancer 2013;60:E67–E69. © 2013 Wiley Periodicals, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research